Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism

Gulhane School of Medicine32 enrolled

Overview

The purpose of this study is investigating the effect of testosterone treatment on paraoxonase level in male patients with hypogonadotrophic hypogonadism

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Masking

NONE

Enrollment

Conditions

Hypogonadism

Interventions

SustanonDRUG

250 mg/21 days

Eligibility

Sex: MALEMin age: 20 YearsMax age: 25 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Volunteers patients with hypogonadism Exclusion Criteria: * Coronary heart disease * Other pituitary/hypothalamic disorders or other non-hypogonadism diseases * None was receiving vitamins, lipid-lowering drugs, or other medications known to interfere with PON1 activity, lipid profile, or gonadal function

Locations (1)

Aydoğan AYDOĞDU

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

paraoxonase level after testosterone treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.